Huang Lab @ UCSF

An incredible group effort from leading investigators from: @ucsfcancer.bsky.social @ucsfchildrens.bsky.social @SeattleChildren @fredhutch.bsky.social @UofR @uofalabama.bsky.social @stjuderesearch.bsky.social h @llsusa.bsky.social @childrensphila.bsky.social @ChildrensMercy @ChildrensATL

Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group PURPOSEHematopoietic stem cell transplantation (HSCT) is used as consolidation for pediatric patients with high-risk AML in first complete remission (CR1). The definition of high-risk AML has evolved ...

Excited to share that our work was published in @JCO_ASCO! A report from the @COGorg: stem cell transplantation is associated with improved outcomes for children diagnosed with high-risk acute myeloid leukemia (AML).

ascopubs.org/doi/10.1200/...

TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia Acute myeloid leukemia (AML) is a heterogeneous cancer that is associated with poor outcomes. Revumenib and other menin inhibitors have shown promising activity against AMLs with KMT2A -rearrangements...

Excited to share our preprint (manuscript in review): TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia.

@ucsfcancer.bsky.social

www.biorxiv.org/content/10.1...